Clofarabine

In the US, Clofarabine (clofarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Lymphoblastic Leukemia.

US matches:

• Clofarabine


• Clofarabine Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BB06

CAS registry number (Chemical Abstracts Service)

0123318-82-1

Chemical Formula

C10-H11-Cl-F-N5-O3

Molecular Weight

303

Therapeutic Categories

Immunosuppressant

Dermatological agent: Antipsoriatic

Antineoplastic agent, antimetabolite

Chemical Names

2-Chlor-9-(2-deoxy-2-fluor-beta-D-arabinofuranosyl)adenin

2-Chlor-9-(2-desoxy-2-fluor-beta-D-arabinofuranosyl)purin-6-amin (IUPAC)

2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine (WHO)

9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- (USAN)

Foreign Names

• Clofarabinum (Latin)
• Clofarabin (German)
• Clofarabine (French)
• Clofarabina (Spanish)

Generic Names

• Clofarabine (OS: USAN, BAN)
• C1-F-Ara-A (IS)
• CAfdA (IS)
• Clofarex (IS)
• Clolar (IS)

Brand Names

• Clolar
  Genzyme, United States



• Evoltra
  Bioenvision, Austria; Bioenvision, Spain; Bioenvision, United Kingdom; Bioenvision, Slovenia; Bioenvision, Slovakia; Bioenvision Limited, Luxembourg; Genzyme, Belgium; Genzyme, Denmark; Genzyme, Finland; Genzyme, France; Genzyme, Greece; Genzyme, Italy; Genzyme, Norway; Genzyme, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.